12/L和(94.55±4.92)g/L,而對照組分別為(2.56±0.38)×1012/L和(73.24±5.39)g/L,都明顯高于治療前(P<0.05),且觀察組也明顯高于對照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論 還原型谷胱甘肽聯(lián)合重組人促紅素治療尿毒癥貧血患者可改善腎功能與貧血狀態(tài),提高治療療效,安全性好,有很好的應(yīng)用推廣價(jià)值。;Objective To explore the effectiveness and safety of reduced glutathione in the treatment of uremic patients with anemia. Methods From January 2014 to May 2016, 84 uremic patients with anemia in our hospital for treatment were selected as the research object and were equally divided into the observation group and control group with 42 patients in each group accorded to the random draw envelope principle. The control group was treated with hemodialysis and oral administration of erythropoietin therapy, the observation group was received the reduced glutathione treatment based on the control group, all patients were observed for 12 weeks. Results There were no serious complications in the two groups. The total effective rate of the observation group and the control group were 97.6% and 85.7% respectively. The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). The serum UA values in observation group and the control group after treatment were significantly lower than that before treatment, the serum Ccr value were significantly higher than before treatment (P<0.05), At the same time after treatment, the serum UA and Ccr values in the observation group compared with the control group were statistical significance difference (P<0.05). The RBC and Hb in the observation group after treatment were (3.38 ±0.34)×1012/L and (94.55 ±4.92) g/L, and the control group were (2.56 ±0.38)×1012/L and (73.24 ±5.39) g/L respectively that were significantly higher than before treatment (P<0.05), and the observation group were significantly higher than those in control group (P<0.05). Conclusion Reduced glutathione in the treatment of uremic anemia can improve renal function and anemia status, improve the therapeutic efficacy, its better safety, and has a good value of application and promotion."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2017年第40卷第10期 >2017,40(10):1464-1467. DOI:10.7501/j.issn.1674-6376.2017.10.021
上一篇 | 下一篇

還原型谷胱甘肽聯(lián)合重組人促紅素治療尿毒癥貧血患者的有效性與安全性

Efficacy and safety of reduced glutathione in the treatment of uremic patients with anemia

發(fā)布日期:2017-11-01
您是第位訪問者
藥物評價(jià)研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031